Contact
searchSearch
HMP Global

Pharmacy Learning Network

PharmLaw

PharmLaw
Ahold Delhaize USA to Pay $40 Million in Drug Price Claims Settlement
06/16/2026
Grace Taylor, MS, MA
Ahold Delhaize USA agreed to pay $40 million to resolve allegations that supermarket pharmacies reported inflated usual and customary drug prices to federal health care programs.
Ahold Delhaize USA agreed to pay $40 million to resolve allegations that supermarket pharmacies reported inflated usual and customary drug prices to federal health care programs.
Ahold Delhaize USA agreed to pay...
06/16/2026
Pharmacy Learning Network
PharmLaw
Tennessee Nurse Practitioner Found Guilty in Controlled-Substance Prescribing Case
06/02/2026
Grace Taylor, MS, MA
A Tennessee nurse practitioner has been convicted of illegally distributing Schedule II opioids, according to the Department of Justice.
A Tennessee nurse practitioner has been convicted of illegally distributing Schedule II opioids, according to the Department of Justice.
A Tennessee nurse practitioner...
06/02/2026
Pharmacy Learning Network
PharmLaw
CVS Challenges Tennessee Law Restricting PBM Ownership of Pharmacies
05/27/2026
Hannah Musick
CVS Health has sued the Tennessee state legislature over a new law barring pharmacy benefit managers (PBMs) from owning pharmacies, setting up a potentially significant legal battle over state authority to regulate vertically integrated...
CVS Health has sued the Tennessee state legislature over a new law barring pharmacy benefit managers (PBMs) from owning pharmacies, setting up a potentially significant legal battle over state authority to regulate vertically integrated...
CVS Health has sued the...
05/27/2026
Pharmacy Learning Network
PharmLaw
North Carolina Reaches $11 Million EpiPen Settlement Over Pricing Practices
05/06/2026
Grace Taylor, MS, MA
North Carolina secured an $11 million settlement with Mylan over alleged EpiPen pricing and rebate practices that impacted Medicaid and state health plan costs.
North Carolina secured an $11 million settlement with Mylan over alleged EpiPen pricing and rebate practices that impacted Medicaid and state health plan costs.
North Carolina secured an $11...
05/06/2026
Pharmacy Learning Network
PharmLaw
Purdue Pharma Sentenced in Federal Opioid Case, Finalizing Fraud and Kickback Conspiracy Resolution
04/29/2026
Grace Taylor, MS, MA
Purdue Pharma’s federal sentencing finalizes a landmark opioid case involving fraud and kickback conspiracies, with lasting compliance implications for the pharmaceutical supply chain.
Purdue Pharma’s federal sentencing finalizes a landmark opioid case involving fraud and kickback conspiracies, with lasting compliance implications for the pharmaceutical supply chain.
Purdue Pharma’s federal...
04/29/2026
Pharmacy Learning Network

FDA Recalls

News
Duloxetine Delayed Release Capsules Recalled Due to CGMP Deviations
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
Extra Strength Antacid Calcium Carbonate Recalled Due to Foreign Contamination
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for extra strength antacid calcium carbonate due to the presence of metallic particles in the product.
The US Food and Drug Administration (FDA) has issued a Class II recall for extra strength antacid calcium carbonate due to the presence of metallic particles in the product.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
Amlodipine and Olmesartan Medoxomil Tablets Recalled Due to Failure to Meet Dissolution Specifications
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for amlodipine and olmesartan medoxomil tablets due to failed dissolution specifications, affecting 15 696 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for amlodipine and olmesartan medoxomil tablets due to failed dissolution specifications, affecting 15 696 bottles.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
MG217 Treatment Cream and Skin Protectant Recalled Due to Staphylococcus Aureus Contamination
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network
News
Pred Mild Eye Drops Recalled Due to Failed Stability Specifications
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for Pred Mild, prednisolone acetate ophthalmic suspension, due to failed stability specifications, affecting 2736 bottles.
The US Food and Drug Administration (FDA) has issued a Class III recall for Pred Mild, prednisolone acetate ophthalmic suspension, due to failed stability specifications, affecting 2736 bottles.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network

In the News

PharmLaw
Ahold Delhaize USA to Pay $40 Million in Drug Price Claims Settlement
06/16/2026
Grace Taylor, MS, MA
Ahold Delhaize USA agreed to pay $40 million to resolve allegations that supermarket pharmacies reported inflated usual and customary drug prices to federal health care programs.
Ahold Delhaize USA agreed to pay $40 million to resolve allegations that supermarket pharmacies reported inflated usual and customary drug prices to federal health care programs.
Ahold Delhaize USA agreed to pay...
06/16/2026
Pharmacy Learning Network
PharmLaw
Federal Court Grants Lilly Preliminary Injunction in $200 Million Drug Rebate Fraud Case
06/11/2026
Hannah Musick
A federal court has granted Eli Lilly a preliminary injunction in its lawsuit alleging a $200 million rebate fraud scheme involving Trulicity, requiring defendants to provide detailed documentation for future rebate claims and signaling...
A federal court has granted Eli Lilly a preliminary injunction in its lawsuit alleging a $200 million rebate fraud scheme involving Trulicity, requiring defendants to provide detailed documentation for future rebate claims and signaling...
A federal court has granted Eli...
06/11/2026
Pharmacy Learning Network
News
Duloxetine Delayed Release Capsules Recalled Due to CGMP Deviations
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
Extra Strength Antacid Calcium Carbonate Recalled Due to Foreign Contamination
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for extra strength antacid calcium carbonate due to the presence of metallic particles in the product.
The US Food and Drug Administration (FDA) has issued a Class II recall for extra strength antacid calcium carbonate due to the presence of metallic particles in the product.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
Amlodipine and Olmesartan Medoxomil Tablets Recalled Due to Failure to Meet Dissolution Specifications
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for amlodipine and olmesartan medoxomil tablets due to failed dissolution specifications, affecting 15 696 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for amlodipine and olmesartan medoxomil tablets due to failed dissolution specifications, affecting 15 696 bottles.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use